198 related articles for article (PubMed ID: 34929067)
1. Potential Fluorinated Anti-MRSA Thiazolidinone Derivatives with Antibacterial, Antitubercular Activity and Molecular Docking Studies.
Kumar V; Shetty P; H S A; Chandra K S; Ramu R; Patil SM; Baliga A; Rai VM; M SS; Udupi V; Poojary V; Poojary B
Chem Biodivers; 2022 Feb; 19(2):e202100532. PubMed ID: 34929067
[TBL] [Abstract][Full Text] [Related]
2. Benzothiazole Clubbed Imidazolone Derivatives: Synthesis, Molecular Docking, DFT Studies, and Antimicrobial Studies.
Desai N; Maheta A; Jethawa A; Ahmad I; Patel H; Dave B
Curr Comput Aided Drug Des; 2023; 19(2):123-136. PubMed ID: 36411562
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.
Nandurkar Y; Bhoye MR; Maliwal D; Pissurlenkar RRS; Chavan A; Katade S; Mhaske PC
Eur J Med Chem; 2023 Oct; 258():115548. PubMed ID: 37307623
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1
Wang J; Hu YH; Zhou KX; Wang W; Li F; Li K; Zhang GY; Tang YZ
Molecules; 2023 May; 28(9):. PubMed ID: 37175382
[TBL] [Abstract][Full Text] [Related]
5. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.
Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ
Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553
[TBL] [Abstract][Full Text] [Related]
7. Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents:
Shinde AD; Nandurkar YM; Bhalekar S; Walunj YS; Ugale S; Ahmad I; Patel H; Chavan AP; Mhaske PC
J Biomol Struct Dyn; 2024; 42(3):1191-1207. PubMed ID: 37254438
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives.
Ates-Alagoz Z; Kisla MM; Goker H; Yildiz S
Med Chem; 2021; 17(7):699-706. PubMed ID: 32310051
[TBL] [Abstract][Full Text] [Related]
9. Exploring the potential of bis(thiazol-5-yl)phenylmethane derivatives as novel candidates against genetically defined multidrug-resistant Staphylococcus aureus.
Kavaliauskas P; Acevedo W; Garcia A; Naing E; Grybaite B; Sapijanskaite-Banevic B; Grigaleviciute R; Petraitiene R; Mickevicius V; Petraitis V
PLoS One; 2024; 19(3):e0300380. PubMed ID: 38517855
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial evaluation and molecular docking studies of pyrazole-thiosemicarbazones and their pyrazole-thiazolidinone conjugates.
Ebenezer O; Singh-Pillay A; Koorbanally NA; Singh P
Mol Divers; 2021 Feb; 25(1):191-204. PubMed ID: 32086698
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial Activity of Quinoline-Based Derivatives against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa: Design, Synthesis, DFT and Molecular Dynamic Simulations.
Sabt A; Abdelraof M; Hamissa MF; Noamaan MA
Chem Biodivers; 2023 Nov; 20(11):e202300804. PubMed ID: 37933986
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, computational molecular docking studies of novel heterocyclics bearing 1,2,4-triazole, 1,3,4-oxadiazole conjugates as potent antibacterial and antitubercular agents.
Sravanthi B; Himavathi G; Robert AR; Karunakar P; Kiran KS; Maddila S
J Biomol Struct Dyn; 2024 Jul; 42(10):5376-5389. PubMed ID: 37340639
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel pleuromutilin derivatives as potent antibacterial agents.
Zhou Y; Yi Y; Wang J; Yang Z; Liu Q; Pu W; Shang R
Eur J Med Chem; 2022 Jul; 237():114403. PubMed ID: 35472849
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA).
Gatadi S; Gour J; Kaul G; Shukla M; Dasgupta A; Akunuri R; Tripathi R; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2018 Dec; 81():175-183. PubMed ID: 30130650
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents.
Zhang QW; Ren J; Lu JX; Chen XY; He XJ; Wang Q; Zhou ZD; Jin Z; Zeng ZL; Tang YZ
Drug Dev Res; 2023 Nov; 84(7):1437-1452. PubMed ID: 37534779
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms.
Garcia MAR; Theodoro RS; Sardi JCO; Santos MB; Ayusso GM; Pavan FR; Costa AR; Santa Cruz LM; Rosalen PL; Regasini LO
Bioorg Chem; 2021 Nov; 116():105279. PubMed ID: 34509799
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimicrobial evaluation of new halogenated 1,3-Thiazolidin-4-ones.
Hammad SG; El-Gazzar MG; Abutaleb NS; Li D; Ramming I; Shekhar A; Abdel-Halim M; Elrazaz EZ; Seleem MN; Bilitewski U; Abouzid KAM; El-Hossary EM
Bioorg Chem; 2020 Jan; 95():103517. PubMed ID: 31884138
[TBL] [Abstract][Full Text] [Related]
20. Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.
Mekky AEM; Sanad SMH
Bioorg Chem; 2020 Sep; 102():104094. PubMed ID: 32711085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
